Additional file 1 of Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

Leach, Amanda Jane; Mulholland, Edward Kim; Santosham, Mathuram; Torzillo, Paul John; McIntyre, Peter; Smith-Vaughan, Heidi; Wilson, Nicole; Arrowsmith, Beth; Beissbarth, Jemima; Chatfield, Mark D.; Oguoma, Victor M.; Morris, Peter Stanley

doi:10.6084/m9.figshare.14183793.v1

12887_2021_2552_MOESM1_ESM.docx (31.16 kB)

Additional file 1 of Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

journal contribution

posted on 2021-03-09, 04:41 authored by Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Peter Stanley Morris

Additional file 1 Supplementary Table 1: Comparisons of proportion of infants with a worst ear diagnosis* of any otitis media or bilateral OM, by vaccine group and age (months).

Funding

National Health and Medical Research Council Financial Markets Foundation for Children

History

Usage metrics

Keywords

Aboriginal Infant Otitis media Pneumococcal conjugate vaccines Combination schedule PCV13 PHiD-CV10 3-arm randomised controlled trial Head-to-head

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC